论文部分内容阅读
目的 :分析研究中西医结合治疗晚期恶性肿瘤的治疗效果。方法 :选取2014年1月-2015年1月在我院接收的晚期恶性肿瘤患者一共有92例,随机分为观察组、对照组,对照组实施西医治疗,观察组实施中西医结合治疗,对两组患者的临床治疗效果给予对比。结果 :临床治疗之前,两组患者的KPS(身体状况)评分和EORTC-QLQ(生活质量)评分之间的差异不具有统计学意义(P>0.05);临床治疗以后,观察组患者的KPS评分和EORTC-QLQ评分明显高于对照组,其之间的差异具有统计学意义(P<0.05);观察组一共有46例,其中CR一共4例(8.69%),PR一共14例(30.43%),NC一共19例(41.3%),PD一共9例(19.56%);对照组一共有46例,其中CR一共3例(6.52%),PR一共10例(21.74%),NC一共15例(32.61%),PD一共18例(39.13%),临床结果显示,临床治疗以后,观察组患者的近期治疗效果显著优于对照组(P<0.05)。结论 :对晚期恶性肿瘤采取中西医结合治疗,可以使患者机体免疫功能得到明显改善,使生存质量进一步提高,具有临床推广价值。
Objective: To analyze the treatment of advanced malignancies treated with integrated traditional Chinese and western medicine. Methods: A total of 92 patients with advanced malignant tumors received in our hospital from January 2014 to January 2015 were randomly divided into observation group, control group and control group. Western medicine treatment was performed in the observation group, The clinical efficacy of the two groups was compared. Results: Before clinical treatment, there was no significant difference between KPS (body condition) score and EORTC-QLQ (quality of life) scores of the two groups (P> 0.05). After the clinical treatment, KPS score And EORTC-QLQ scores were significantly higher than those in the control group (P <0.05). There were 46 cases in the observation group, including 4 cases of CR (8.69%) and 14 cases of PR (30.43% ), A total of 19 cases of NC (41.3%), PD a total of 9 cases (19.56%); control group, a total of 46 cases, including CR in a total of 3 cases (6.52%), PR a total of 10 cases (21.74% (32.61%). There were 18 cases (39.13%) of PD. The clinical results showed that the treatment effect of the observation group was significantly better than that of the control group after the clinical treatment (P <0.05). Conclusion: The treatment of advanced malignant tumor with integrated traditional Chinese and western medicine can improve the immune function and improve the quality of life of patients with further clinical promotion.